Products

OKEDI® (risperidone) powder and solvent for prolonged-release suspension for injection pre-filled syringes (75 mg / 100 mg)

AROVI® (enoxaparin sodium) pre-filled syringe with safety device (2,000 IU (20 mg/0.2 mL) 4,000 IU (40 mg/0.4 mL)
6,000 IU (60 mg/0.6 mL) 8,000 IU (80 mg/0.8 mL) 10,000 IU (100 mg/1 mL) 12,000 IU (120 mg/0.8 mL) 15,000 IU (150 mg/1mL))

Heparin sodium vials (5,000 IU in 5mL (1,000 IU/ml) / 25,000 IU in 5 mL (5,000 IU in 1 ML))

Learn more

Disease awareness information for the general public

Information for patients who have been prescribed a ROVI® treatment

Information for UK healthcare professionals.

Adverse event reporting

Healthcare professionals

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme 
https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play 
or Apple App Store. Adverse events should also be reported to ROVI UK Ltd. on 
+44 (0) 203 642 06 77 or by email to uk-pharmacovigilance@rovi.com.

Patients and the public

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via Yellow Card Scheme Website: https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk/ for how to report side effects.